Bioprospecting and Incentives for Biodiversity Conservation: Lessons from the History of Paclitaxel

George B. Frisvold ()
Additional contact information
George B. Frisvold: University of Arizona

A chapter in Sustainable Resource Development in the 21st Century, 2023, pp 179-206 from Springer

Abstract: Abstract Plants and other organisms remain an important source of new medicines, either directly or as sources of molecular building blocks or information for drug development. Bioprospecting contracts between pharmaceutical companies and species-rich source countries have been touted as a way for developing countries to capture greater gains from their genetic resources and to increase their incentives to preserve their biodiversity. This case study of the discovery and commercial development of the anticancer drug paclitaxel from the Pacific yew tree highlights neglected issues in debates over bioprospecting and conservation incentives. Paclitaxel’s discovery, commercialization, and resource use illustrate how bioprospecting can substitute one biodiversity threat (habitat conversion, when genetic resources are not valued) for another threat (overharvesting, when they are valued). Whether creation of market demand for genetic resources encourages or discourages biodiversity conservation depends crucially on underlying property rights and management regimes for common property resources.

Date: 2023
References: Add references at CitEc
Citations:

There are no downloads for this item, see the EconPapers FAQ for hints about obtaining it.

Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:spr:nrmchp:978-3-031-24823-8_14

Ordering information: This item can be ordered from
http://www.springer.com/9783031248238

DOI: 10.1007/978-3-031-24823-8_14

Access Statistics for this chapter

More chapters in Natural Resource Management and Policy from Springer
Bibliographic data for series maintained by Sonal Shukla () and Springer Nature Abstracting and Indexing ().